Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07577479
PHASE1

A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

Official title: A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of A Single Dose of BW-50218 in Healthy Chinese Participants

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-05-15

Completion Date

2028-04-30

Last Updated

2026-05-11

Healthy Volunteers

Yes

Interventions

DRUG

BW-50218 Injection

Solution for injection

DRUG

Saline (0.9% NaCl)

Solution for injection

Locations (1)

Argo Investigative Site

Shanghai, China